SamarasK, WandH, LawM, EmeryS, CooperD, CarrA. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia. Diabetes Care, 2007; 30:113–119.
2.
WandH, CalmyA, CareyDLet al.Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS, 2007; 21:2445–2453.
3.
The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: Collaborative analysis of 13 HIV cohort studies. Clin Infect Dis, 2010; 50:1387–1396.
4.
MuggeoM, VerlatoG, BonoraEet al.The Verona Diabetes Study: A population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia, 1995; 38:318–325.
5.
BarbiniN, GoriniG, FerrucciL, BuggeriA. Il ruolo svolto dall'attività lavorative sull'ipertensione arteriosa. G Ital Med Lav Ergon, 2007; 29:174–181.
